PP
CORV

Pacifica Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Pacifica Partners’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,665
Closed -$1K – 420
2020
Q1 		$1K Hold
2,665
– – ﹤0.01% 369
2019
Q4 		$1K Buy
+2,665
New +$4.42K ﹤0.01% 361

Pacifica Partners's CORV Position: Q2 2020 in Review

Pacifica Partners sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2020, closing a stake of 2,665 shares — an estimated $1K sold.

Pacifica Partners first reported a position in CORV in Q4 2019 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 0 funds tracked by Wall St. Rank hold CORV as of Q2 2020.

  • Pacifica Partners reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2020 after selling out during the quarter.
  • Pacifica Partners sold 2,665 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2020, an estimated $1K.
  • Pacifica Partners first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2019 and held it in 2 quarters.
  • Pacifica Partners's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $1K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2020.

Based on Pacifica Partners's 13F filing for Q2 2020, filed 15 Jul 2020.